Who invested in ABAC Therapeutics?
ABAC Therapeutics's investors include Criteria Venture Tech.

Funding summaryUpdated 26 Oct 2026
$20Mraised across 1 round since 2018, from 1 source
ABAC Therapeutics's investors include Criteria Venture Tech.
ABAC Therapeutics has raised $20M across 1 round since 2018.
ABAC Therapeutics's most recent round was a Series A of $20M in Feb 2018.
Its most recent round, $20M in Feb 2018, is also its largest on record.
ABAC Therapeutics's first round on record, in Feb 2018, was backed by Criteria Venture Tech.
ABAC Therapeutics's latest named round is a Series A, in Feb 2018.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.